Form 8-K - Current report:
SEC Accession No. 0001628280-24-040982
Filing Date
2024-09-20
Accepted
2024-09-20 08:32:40
Documents
17
Period of Report
2024-09-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20240919.htm   iXBRL 8-K 30245
2 EX-10.1 ozan_pamirxofferxletter.htm EX-10.1 6259
3 EX-99.1 pressreleasedatedseptember.htm EX-99.1 16751
7 GRAPHIC ozan_pamirxofferxletter001.jpg GRAPHIC 189509
8 GRAPHIC ozan_pamirxofferxletter002.jpg GRAPHIC 224730
  Complete submission text file 0001628280-24-040982.txt   757037

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20240919.xsd EX-101.SCH 1895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20240919_lab.xml EX-101.LAB 21689
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20240919_pre.xml EX-101.PRE 12519
19 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20240919_htm.xml XML 2733
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 241311747
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)